(Q37130693)

18 August 2017

Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests (English)

1 reference

18 August 2017

1 reference

2

Barry AL

1 reference

18 August 2017

3

Fuchs PC

1 reference

18 August 2017

1

Pfaller MA

1 reference

PMCID

265662

18 August 2017

language of work or name

English

0 references

publication date

1 July 1993

1 reference

Journal of Clinical Microbiology

18 August 2017

1 reference

18 August 2017

31

1 reference

18 August 2017

1924-1926

1 reference

18 August 2017

7

1 reference

Proposed disk diffusion susceptibility criteria for ofloxacin.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=265662

Pharmacokinetics of ofloxacin after parenteral and oral administration

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=265662

In vitro activity of DR-3355, an optically active ofloxacin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=265662

Temafloxacin disk potency and tentative interpretive criteria for susceptibility tests

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=265662

In vitro activity of S-ofloxacin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=265662

Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=265662

In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=265662

Enantioselective disposition of ofloxacin in humans

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=265662

Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=265662

A comparison of antimicrobial activity of ofloxacin, L-ofloxacin, and other oral agents for respiratory pathogens

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=265662

In vitro activity of l-ofloxacin against norfloxacin-resistant coagulase-negative staphylococci

27 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8349777

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/JCM.31.7.1924-1926.1993

0 references

PMCID

265662

1 reference

18 August 2017

1 reference

PMCID

265662